Consequences of peripheral vasculopathy, which includes Raynaud’s phenomenon, were being observed in postmarketing experiences and at the therapeutic dosages of CNS stimulants in all age teams through the system of cure. Symptoms and signs or symptoms commonly enhanced immediately after dosage reduction or discontinuation of your CNS stimulant.Li